SENP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.904250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.496400E-01
Normal-vs-Stage2
1.316160E-01
Normal-vs-Stage3
4.719900E-02
Normal-vs-Stage4
8.117600E-02
Stage1-vs-Stage2
5.220800E-01
Stage1-vs-Stage3
2.911000E-01
Stage1-vs-Stage4
5.121400E-01
Stage2-vs-Stage3
2.268600E-01
Stage2-vs-Stage4
7.581600E-01
Stage3-vs-Stage4
4.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.183400E-01
Normal-vs-AfricanAmerican
5.340700E-03
Normal-vs-Asian
8.844400E-02
Caucasian-vs-AfricanAmerican
4.972600E-01
Caucasian-vs-Asian
6.344800E-01
AfricanAmerican-vs-Asian
3.762600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.831500E-02
Normal-vs-Female
3.878800E-01
Male-vs-Female
1.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.859200E-01
Normal-vs-Age(41-60Yrs)
4.608600E-01
Normal-vs-Age(61-80Yrs)
6.440100E-02
Normal-vs-Age(81-100Yrs)
1.737430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.824000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.040000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.050200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.498090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.997000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.382200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.682620E-01
Normal-vs-Daily Drinker
4.350100E-02
Normal-vs-Weekly Drinker
4.381600E-01
Normal-vs-Occasional Drinker
3.523000E-01
Normal-vs-Social Drinker
2.838600E-01
Non Drinker-vs-Daily Drinker
7.391200E-01
Non Drinker-vs-Weekly Drinker
2.152200E-01
Non Drinker-vs-Occasional Drinker
2.862000E-01
Non Drinker-vs-Social Drinker
2.334600E-01
Daily Drinker-vs-Weekly Drinker
2.068600E-01
Daily Drinker-vs-Occasional Drinker
1.320970E-01
Daily Drinker-vs-Social Drinker
7.955900E-02
Weekly Drinker-vs-Occasional Drinker
6.903000E-01
Weekly Drinker-vs-Social Drinker
7.658000E-01
Occasional Drinker-vs-Social Drinker
8.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.410800E-01
Normal-vs-Grade 2
6.896400E-01
Normal-vs-Grade 3
7.046600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.171650E-01
Grade 1-vs-Grade 3
3.154400E-01
Grade 1-vs-Grade 4
7.410800E-01
Grade 2-vs-Grade 3
4.321400E-01
Grade 2-vs-Grade 4
6.896400E-01
Grade 3-vs-Grade 4
7.046600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.806500E-02
Normal-vs-NonDiabetic
2.908400E-01
Diabetic-vs-NonDiabetic
6.356000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.178400E-01
Normal-vs-NoPancreatitis
2.285600E-01
Pancreatitis-vs-NoPancreatitis
8.265400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.479000E-01
Normal-vs-N1
1.409030E-01
N0-vs-N1
2.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.190200E-02
Normal-vs-TP53-NonMutant
4.034400E-01
TP53-Mutant-vs-TP53-NonMutant
8.277500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
